Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-24-000245
Filing Date
2024-10-30
Accepted
2024-10-30 11:54:10
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20240930.htm   iXBRL 10-Q 2176358
2 EX-31.1 lly-09302024x10qxex3111.htm EX-31.1 10587
3 EX-31.2 lly-09302024x10qxex3121.htm EX-31.2 10618
4 EX-32 lly-09302024x10qxexhibit321.htm EX-32 7083
  Complete submission text file 0000059478-24-000245.txt   11215826

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20240930.xsd EX-101.SCH 50874
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20240930_cal.xml EX-101.CAL 75319
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20240930_def.xml EX-101.DEF 267563
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20240930_lab.xml EX-101.LAB 670900
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20240930_pre.xml EX-101.PRE 459671
78 EXTRACTED XBRL INSTANCE DOCUMENT lly-20240930_htm.xml XML 2628360
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 241408501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)